Alnylam Pharmaceuticals, Inc. lobbies on its own behalf. For Q3 2026 it reported $470K across 1 client report and lists 3 lobbyists across its filings. Issues include Medicare/Medicaid, Pharmacy and Trade (domestic/foreign).
| Client | Reported | Issues |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | $470K | Medicare/Medicaid, Pharmacy, Trade (domestic/foreign) |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $1.35M | 1 |
| 2025 | $1.61M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.